{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:17:07Z","timestamp":1794435427597,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PhD Research Fund of the Affiliated Hospital of the Southwest Medical University","award":["16238"],"award-info":[{"award-number":["16238"]}]},{"name":"Luzhou city: Southwest Medical University Joint Project","award":["2017LZXNYD-PO2"],"award-info":[{"award-number":["2017LZXNYD-PO2"]}]},{"name":"Scientific Research Fund of Southwest Medical University","award":["0930-00031081"],"award-info":[{"award-number":["0930-00031081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human Papilloma Virus (HPV) DNA tests are highly sensitive and can triage women with mild lesions, improving the prognosis and diagnosis of cervical lesions. However, additional efficient strategies should be developed to improve the specificity of these tests.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study aimed to evaluate the clinical value of HPV DNA load in improving the diagnosis and prognosis of cervical lesions by p16\/Ki-67 testing. Histological samples were collected from 350 women with HR-HPV genotyping and analyzed by qRT-PCR. Immunohistochemical staining was used to assess p16 and Ki-67 expression and clinical performance characteristics were calculated.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the cases, 271 had detectable HR-HPV infection, in which HPV-16 was most prevalent (52.0%), followed by HPV-58 (22.5%). P16\/Ki-67-positivity increased with histological severity but not for HR-HPV infection. Amongst the 13 HR-HPV genotypes, only HPV-16 (<jats:italic>P<\/jats:italic>\u2009=\u20090.016) and HPV-58 (<jats:italic>P<\/jats:italic>\u2009=\u20090.004) viral loads significantly correlated with lesion severity. The P16\/Ki-67\/HPV DNA load co-test indicated an increased sensitivity for the detection of cervical intraepithelial neoplasia (CIN) lesions compared to p16\/Ki-67 staining in HPV-16 and\/or 58 positive cases. Viral load did not improve the sensitivity of p16\/Ki-67 co-test in non-HPV-16 or 58 positive cases. The clinical performance of the p16\/Ki-67\/HPV DNA load co-test was limited for the prediction of the outcome of CIN1 lesions. However, amongst the 12 HPV-16 and\/or 58 positive CIN2 cases in which return visit results were obtained, the behavior of the lesions could be predicted, with a sensitivity, specificity, positive prediction rate (PPV), and negative prediction rate (NPV) of 0.667, 1, 1 and 0.5, respectively.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Combination of the assessment of HPV DNA load with the intensity of p16 and Ki-67 staining could increase the sensitivity of CIN lesion diagnosis and predict the outcome of CIN2 in patients with a HPV-16 and\/or 58 infection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-019-1225-6","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T10:03:55Z","timestamp":1571220235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Combining HPV DNA load with p16\/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1\u20132 lesions"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuejie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-685X","authenticated-orcid":false,"given":"Wenbo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"issue":"1","key":"1225_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1743-422X-8-269","volume":"8","author":"R Faridi","year":"2011","unstructured":"Faridi R, Zahra A, Khan K, et al. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J. 2011;8(1):269.","journal-title":"Virol J"},{"key":"1225_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3332\/ecancer.2015.526","volume":"9","author":"R Ghittoni","year":"2015","unstructured":"Ghittoni R, Accardi R, Chiocca S, et al. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015;9:526.","journal-title":"Ecancermedicalscience."},{"issue":"9","key":"1225_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","volume":"12","author":"PE Castle","year":"2011","unstructured":"Castle PE, Stoler MH, Wright TC Jr, et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 2011;12(9):880\u201390.","journal-title":"Lancet Oncol"},{"issue":"10","key":"1225_CR4","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/ijc.29971","volume":"138","author":"SR Skinner","year":"2016","unstructured":"Skinner SR, Wheeler CM, Romanowski B, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: analysis of the control arm of the VIVIANE study. Int J Cancer. 2016;138(10):2428\u201338.","journal-title":"Int J Cancer"},{"issue":"11","key":"1225_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jclinpath-2018-205271","volume":"71","author":"VZ Marjolein","year":"2018","unstructured":"Marjolein VZ, Annemiek L, Kremer WW, et al. Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions. J Clin Pathol. 2018;71(11):981\u20138.","journal-title":"J Clin Pathol"},{"issue":"3","key":"1225_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","volume":"35","author":"I Tsoumpou","year":"2009","unstructured":"Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009;35(3):210\u201320.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1225_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/01.pgp.0000139639.79105.40","volume":"23","author":"M Branca","year":"2004","unstructured":"Branca M, Ciotti M, Santini D, et al. p16INK4A expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol. 2004;23(4):354\u201365.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"1225_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3802\/jgo.2008.19.3.162","volume":"19","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Kim JW, Hong JW, et al. Expression of the p16INK4a and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol. 2008;19(3):162\u20138.","journal-title":"J Gynecol Oncol"},{"key":"1225_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/modpathol.2016.80","volume":"29","author":"R Luttmer","year":"2016","unstructured":"Luttmer R, Dijkstra MG, Snijders PJ, et al. p16\/Ki-67 dual-stained cytology for detecting cervical (pre) cancer in a HPV-positive gynecologic outpatient population. Mod Pathol. 2016;29:870\u20138.","journal-title":"Mod Pathol"},{"key":"1225_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/modpathol.2017.16","volume":"30","author":"RM Ebisch","year":"2017","unstructured":"Ebisch RM, van der Horst J, Hermsen M, et al. Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. Mod Pathol. 2017;30:1021\u201331.","journal-title":"Mod Pathol"},{"issue":"15","key":"1225_CR11","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","volume":"18","author":"N Wentzensen","year":"2012","unstructured":"Wentzensen N, Schwartz L, Zuna RE, et al. Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18(15):4154\u201362.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1225_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","volume":"144","author":"TC Wright Jr","year":"2009","unstructured":"Wright TC Jr, Behrens CM, Ranger-Moore J, et al. Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial. Gynecol Oncol. 2009;144(1):51.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1225_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1479-5876-7-25","volume":"7","author":"CL Koo","year":"2009","unstructured":"Koo CL, Kok LF, Lee MY, et al. Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantl. J Transl Med. 2009;7(1):25.","journal-title":"J Transl Med"},{"issue":"5","key":"1225_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/AOG.0b013e3181fa7d13","volume":"116","author":"M Schiffman","year":"2010","unstructured":"Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer. Obstet Gynecol. 2010;116(5):221\u20132.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1225_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/1055-9965.EPI-12-0953-T","volume":"22","author":"K Sundstr\u00f6m","year":"2013","unstructured":"Sundstr\u00f6m K, Ploner A, Dahlstr\u00f6m LA, et al. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer. Cancer Epidemiol Biomark Prev. 2013;22(1):150\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1225_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ijc.29374","volume":"137","author":"LT Thomsen","year":"2015","unstructured":"Thomsen LT, Frederiksen K, Munk C, et al. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology. Int J Cancer. 2015;137(1):193\u2013203.","journal-title":"Int J Cancer"},{"issue":"1","key":"1225_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12985-017-0751-3","volume":"14","author":"Y Tang","year":"2017","unstructured":"Tang Y, Zheng L, Yang S, et al. Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women. Virol J. 2017;14(1):84.","journal-title":"Virol J"},{"issue":"1","key":"1225_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12985-018-1003-x","volume":"15","author":"W Long","year":"2018","unstructured":"Long W, Yang Z, Li X, et al. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J. 2018;15(1):94.","journal-title":"Virol J"},{"key":"1225_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/PGP.0b013e31821ac4fd","volume":"30","author":"LB Gatta","year":"2011","unstructured":"Gatta LB, Berenzi A, Balzarini P, et al. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial Neoplasia. Int J Gynecol Pathol. 2011;30:597\u2013604.","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"1225_CR20","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/ijc.30609","volume":"140","author":"S Mittal","year":"2017","unstructured":"Mittal S, Basu P, Muwonge R, et al. Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN1 at baseline-a population-based cohort study. Int J Cancer. 2017;140(8):1850\u20139.","journal-title":"Int J Cancer"},{"issue":"9295","key":"1225_CR21","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0140-6736(01)06809-X","volume":"358","author":"MA Nobbenhuis","year":"2001","unstructured":"Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet. 2001;358(9295):1782\u20133.","journal-title":"Lancet."},{"issue":"3","key":"1225_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cncy.20139","volume":"119","author":"K Atkins","year":"2001","unstructured":"Atkins K. p16\/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: p16\/Ki-67 in cervical Papanicolaou tests. Cancer Cytopathol. 2001;119(3):145\u20137.","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"1225_CR23","first-page":"26","volume":"120","author":"M Singh","year":"2012","unstructured":"Singh M, Mockler D, Akalin A, et al. Immunocytochemical colocalization of p16INK4a and Ki-67 predicts CIN2\/3 and AIS\/adenocarcinoma: pilot studies. Cancer. 2012;120(1):26\u201334.","journal-title":"Cancer."},{"issue":"2","key":"1225_CR24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3892\/ol.2015.4071","volume":"11","author":"S Lim","year":"2016","unstructured":"Lim S, Lee MJ, Cho I, et al. Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group. Oncol Lett. 2016;11(2):1447\u201352.","journal-title":"Oncol Lett"},{"issue":"3","key":"1225_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/apm.12338","volume":"123","author":"LB da Costa","year":"2015","unstructured":"da Costa LB, Triglia Rde M, Fran\u00e7a Junior MC, et al. p16(INK) (4a) expression as a potential marker of low-grade cervical intraepithelial neoplasia progression. APMIS. 2015;123(3):185\u20139.","journal-title":"APMIS."},{"issue":"2","key":"1225_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/PAP.0b013e3182862aab","volume":"20","author":"M Herfs","year":"2013","unstructured":"Herfs M, Crum CP. Laboratory management of cervical intraepithelial Neoplasia: proposing a new paradigm. Adv Anat Pathol. 2013;20(2):86\u201394.","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"1225_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ostor","year":"1993","unstructured":"Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186\u201392.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"1225_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jcp.2010.083626","volume":"64","author":"IT Ovestad","year":"2011","unstructured":"Ovestad IT, Gudlaugsson E, Skaland I, et al. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3. J Clin Pathol. 2011;64(4):303\u20137.","journal-title":"J Clin Pathol"},{"issue":"5","key":"1225_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bpobgyn.2011.04.005","volume":"25","author":"CM Martin","year":"2011","unstructured":"Martin CM, John J, O\u2019Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Cl Ob. 2011;25(5):605\u201315.","journal-title":"Best Pract Res Cl Ob"},{"issue":"3","key":"1225_CR30","first-page":"2979","volume":"8","author":"P Zhong","year":"2015","unstructured":"Zhong P, Li J, Gu Y, et al. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1. Int J Clin Exp Pathol. 2015;8(3):2979\u201386.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1225_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.humpath.2013.10.014","volume":"45","author":"RJ Litjens","year":"2014","unstructured":"Litjens RJ, Van de Vijver KK, Hopman AH, et al. The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3. Human Pathol. 2014;45(2):221\u20136.","journal-title":"Human Pathol"},{"issue":"3","key":"1225_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/PGP.0000000000000326","volume":"36","author":"C Liu","year":"2017","unstructured":"Liu C, Du H, Wang C. HPV L1 and P16 expression in CIN1 to predict future CIN2. Int J Gynecol Pathol. 2017;36(3):281\u20138.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"1225_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/PAS.0000000000000747","volume":"41","author":"AM Mills","year":"2016","unstructured":"Mills AM, Paquette C, Terzic T, et al. CK7 immunohistochemistry as a predictor of CIN1 progression: a retrospective study of patients from the Quadrivalent HPV vaccine trials. Am J Surg Pathol. 2016;41(2):143\u201352.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1225_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3802\/jgo.2013.24.3.215","volume":"24","author":"S Nishio","year":"2013","unstructured":"Nishio S, Fujii T, Nishio H, et al. p16INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J Gynecol Oncol. 2013;24(3):215\u201321.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"1225_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM de Villiers","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324(1):17\u201327.","journal-title":"Virology."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1225-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1225-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1225-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:17:08Z","timestamp":1602717428000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1225-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1225-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"21 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was examined by the ethics committee of the Affiliated Hospital of Southwest Medical University. The research content and design of the project are in line with the ethical norms. The project was agreed to carry out.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}